Parth Mehrotra - 10 Mar 2026 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
Chief Executive Officer, Director
Signature
/s/ Anita Beth Adams, as attorney-in-fact
Issuer symbol
PRVA
Transactions as of
10 Mar 2026
Net transactions value
-$479,113
Form type
4
Filing time
12 Mar 2026, 17:47:33 UTC
Previous filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mehrotra Parth Chief Executive Officer, Director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON /s/ Anita Beth Adams, as attorney-in-fact 12 Mar 2026 0001858398

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Sale $479,113 -21,097 -6.1% $22.71 322,698 10 Mar 2026 Direct F1, F2
transaction PRVA Common Stock, $0.01 par value per share Award +141,342 +44% $0.000000* 464,040 10 Mar 2026 Direct F3
transaction PRVA Common Stock, $0.01 par value per share Award +171,904 +37% $0.000000* 635,944 11 Mar 2026 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person .
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.27 to $23.23 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.
F4 Vesting and distribution to reporting person of 141,948 shares underlying performance stock units that were granted on May 9, 2023, and 29,956 shares underlying performance stock units that were granted on July 1, 2023, in both cases for the performance period 2023-2025.